Agency Information Collection Activities: Proposed Collection; Comment Request, 321-322 [2024-31567]
Download as PDF
Federal Register / Vol. 90, No. 2 / Friday, January 3, 2025 / Notices
with regard to regulation of laboratories
participating in CLIA. The surveyor will
provide the laboratory with the CMS–
209 form. While the surveyor performs
other aspects of the survey, the
laboratory will complete the CMS–209
by recording the personnel data needed
to support their compliance with the
personnel requirements of CLIA. For
this submission, we are making minor
revisions to the collection instrument.
We revised the instructions for clarity
and removed the references to specific
regulations. Form Number: CMS–209
(OMB control number 0938–0151);
Frequency: Biennially; Affected Public:
Private Sector—State, Local, or Tribal
Governments; and Federal Government;
Number of Respondents: 16,404; Total
Annual Responses: 8,202; Total Annual
Hours: 4,101. (For policy questions
regarding this collection contact Penny
Keller at 410–786–2035.)
William N. Parham, III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–31553 Filed 1–2–25; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10565 and
CMS–1763]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
FOR FURTHER INFORMATION CONTACT:
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
Contents
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10565 Medicare Advantage
Model of Care Submission
Requirements
CMS–1763 Request for Termination of
Medicare Premium Part A, Part B, or
Part B Immunosuppressive Drug
Coverage (Part B–ID) and Supporting
Statute and Regulations
Under the PRA (44 U.S.C. 3501–
3520), Federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
AGENCY:
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
March 4, 2025.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
VerDate Sep<11>2014
18:01 Jan 02, 2025
Jkt 265001
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
321
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires Federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collections
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Advantage Model of Care Submission
Requirements; Use: Section 1859(f)(7) of
the Act and 42 CFR 422.101(f)(3)
requires that all SNP MOCs be approved
by NCQA. This approval is based on
NCQA’s evaluation of SNPs’ MOC
narratives using MOC scoring
guidelines. Section 50311 of the BBA of
2018 modified the MOC requirements
for C–SNPs in section 1859 (f)(5)(B)(i-v)
of the Act, requiring them to submit on
an annual basis. The BBA mandated
additional changes for C–SNPs related
to care management, HRAs,
individualized care plans, a minimum
benchmark for scoring, etc., for which
CMS has applied these requirements to
all SNP types.
SNPs will submit initial and renewal
MOCs as well as summaries of any
substantive off-cycle MOC changes to
CMS through HPMS. This is the
platform that CMS uses to coordinate
communication and the collection of
information from MAOs.
NCQA and CMS will use information
collected in the SNP Application HPMS
module to review and approve MOC
narratives in order for an MAO to offer
a new SNP in the upcoming calendar
year(s). This information is used by
CMS as part of the MA SNP application
process. NCQA and CMS will use
information collected in the Renewal
Submission section of the HPMS MOC
module to review and approve the MOC
narrative for the SNP to receive a new
approval period and operate in the
upcoming calendar year(s). Form
Number: CMS–10565 (OMB control
number 0938–1296); Frequency:
Occasionally; Affected Public: Private
Sector, Business or other for-profits;
Number of Respondents: 2,088; Total
Annual Responses: 2,088; Total Annual
Hours: 8,638. (For policy questions
regarding this collection contact Daniel
E:\FR\FM\03JAN1.SGM
03JAN1
322
Federal Register / Vol. 90, No. 2 / Friday, January 3, 2025 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Lehman at 410–786–8929 or
daniel.lehman@cms.hhs.gov.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Request for
Termination of Medicare Premium Part
A, Part B, or Part B Immunosuppressive
Drug Coverage (Part B–ID) and
Supporting Statute and Regulations;
Use: Sections 1818(c)(5), 1818A(c)(2)(B)
and 1838(b)(1) of the Act and
corresponding regulations at 42 CFR
406.28(a) and 407.27(c) require that a
Medicare enrollee wishing to
voluntarily terminate Part B or premium
Part A coverage file a written request
with CMS or SSA. Pursuant to 1838(h)
of the Act and the corresponding
regulation at 42 CFR 407.62(a),
individuals wishing to terminate their
Part B–ID coverage must notify SSA.
The statute and regulations also specify
when coverage ends based upon the
date the request for termination is filed.
The CMS–1763 is the form used by
individuals who wish to terminate their
Medicare Part A, Part B or Part B–ID.
This 2024 iteration is a revision that
does not propose any program changes.
Per the Office of Communication’s plain
language suggestion, the title has been
updated to ‘‘Request for Termination of
Medicare Premium Part A, Part B, or
Part B Immunosuppressive Drug
Coverage (Part B–ID).’’ The 2024
submission saw an increase in the
burden due to utilization of the form
and improvement in the accuracy of the
data exchanges between CMS and SSA.
Updated wage information for a Federal
Government employee is also
responsible for part of the increase.
Form Number: CMS–1763 (OMB control
number 0938–0025); Frequency:
Biennially; Affected Public: Private
Sector—State, Local, or Tribal
Governments; and Federal Government;
Number of Respondents: 197,518; Total
Annual Responses: 197,518; Total
Annual Hours: 33,578. (For policy
questions regarding this collection
contact Tyrissa Woods at 410–786–0286
or tyrissa.woods@cms.hhs.gov.)
William N. Parham, III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–31567 Filed 1–2–25; 8:45 am]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
18:01 Jan 02, 2025
Jkt 265001
ALLOTMENT **—Continued
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
State
Administration for Children and
Families
[CFDA Number(s): 93.645]
Notice of Allotment Percentages to
States for Child Welfare Services State
Grants; Correction
Administration for Children
and Families, Department of Health and
Human Services.
ACTION: Notice; correction.
AGENCY:
The Administration for
Children and Families published a
document in the Federal Register
published Wednesday, December 4,
2024, concerning notice of Allotment
Percentages to States for Child Welfare
Services State Grants. The formula used
to calculate the allotment percentages
for each state was not applied correctly.
Although the percentage for the State of
Alabama percentage was calculated
correctly, the formula used to calculate
the allotment percentages was not
correctly applied to the remaining
states.
FOR FURTHER INFORMATION CONTACT:
Sona Cook, 214–767–2973.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Correction
In the Federal Register of December 4,
2024, in FR Doc. 2024–28398, on page
96256, in the second and third columns,
the ALLOTMENT table contained an
incorrect formula for the Allotment
Percentages to States for Child Welfare
Services State Grants. The updated
ALLOTMENT table with the correct
allotment percentage for each State is as
follows:
ALLOTMENT **
State
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
Maryland ...............................
Massachusetts ......................
Michigan ...............................
Minnesota .............................
Mississippi ............................
Missouri ................................
Montana ................................
Nebraska ..............................
Nevada .................................
New Hampshire ....................
New Jersey ...........................
New Mexico ..........................
New York ..............................
North Carolina ......................
North Dakota ........................
Ohio ......................................
Oklahoma .............................
Oregon ..................................
Pennsylvania ........................
Rhode Island ........................
South Carolina ......................
South Dakota ........................
Tennessee ............................
Texas ....................................
Utah ......................................
Vermont ................................
Virginia ..................................
Washington ...........................
West Virginia ........................
Wisconsin .............................
Wyoming ...............................
America Samoa ....................
Guam ....................................
Puerto Rico ...........................
N. Mariana Islands ...............
Virgin Islands ........................
46.19
35.02
56.10
47.65
64.18
55.55
53.73
49.64
52.74
43.28
41.18
60.32
41.19
55.66
47.82
55.81
56.84
51.55
50.59
51.41
58.86
47.83
55.38
52.76
54.33
52.28
47.50
42.58
62.16
53.26
42.78
70.00
70.00
70.00
70.00
70.00
Anthony Petruccelli,
Senior Grants Policy Specialist, Office of
Grants Policy, Office of Administration.
[FR Doc. 2024–31515 Filed 1–2–25; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Percentage
Alabama ................................
Alaska * .................................
Arizona ..................................
Arkansas ...............................
California ...............................
Colorado ...............................
Connecticut ...........................
Delaware ...............................
District of Columbia 1 ............
Florida ...................................
Georgia .................................
Hawaii * .................................
Idaho .....................................
Illinois ....................................
Indiana ..................................
Iowa ......................................
Kansas ..................................
Kentucky ...............................
Louisiana ..............................
Maine ....................................
Percentage
61.01
48.58
55.49
58.66
41.38
43.03
35.99
52.51
30.00
51.25
56.80
52.67
57.12
48.26
55.74
54.48
53.25
60.14
57.73
53.63
[Docket No. FDA–2024–N–5784]
Interested Parties Meeting:
Implementation of the Best
Pharmaceuticals for Children Act and
Pediatric Research Equity Act
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meeting;
request for comments.
ACTION:
The Food and Drug
Administration’s (FDA, Agency, or we)
Office of Pediatric Therapeutics, the
Center for Drug Evaluation and
Research, and the Center for Biologics
Evaluation and Research are
announcing a public meeting entitled
‘‘Interested Parties Meeting:
SUMMARY:
E:\FR\FM\03JAN1.SGM
03JAN1
Agencies
[Federal Register Volume 90, Number 2 (Friday, January 3, 2025)]
[Notices]
[Pages 321-322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31567]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10565 and CMS-1763]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), Federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of information
(including each proposed extension or reinstatement of an existing
collection of information) and to allow 60 days for public comment on
the proposed action. Interested persons are invited to send comments
regarding our burden estimates or any other aspect of this collection
of information, including the necessity and utility of the proposed
information collection for the proper performance of the agency's
functions, the accuracy of the estimated burden, ways to enhance the
quality, utility, and clarity of the information to be collected, and
the use of automated collection techniques or other forms of
information technology to minimize the information collection burden.
DATES: Comments must be received by March 4, 2025.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number: __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10565 Medicare Advantage Model of Care Submission Requirements
CMS-1763 Request for Termination of Medicare Premium Part A, Part B, or
Part B Immunosuppressive Drug Coverage (Part B-ID) and Supporting
Statute and Regulations
Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires Federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collections
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare
Advantage Model of Care Submission Requirements; Use: Section
1859(f)(7) of the Act and 42 CFR 422.101(f)(3) requires that all SNP
MOCs be approved by NCQA. This approval is based on NCQA's evaluation
of SNPs' MOC narratives using MOC scoring guidelines. Section 50311 of
the BBA of 2018 modified the MOC requirements for C-SNPs in section
1859 (f)(5)(B)(i-v) of the Act, requiring them to submit on an annual
basis. The BBA mandated additional changes for C-SNPs related to care
management, HRAs, individualized care plans, a minimum benchmark for
scoring, etc., for which CMS has applied these requirements to all SNP
types.
SNPs will submit initial and renewal MOCs as well as summaries of
any substantive off-cycle MOC changes to CMS through HPMS. This is the
platform that CMS uses to coordinate communication and the collection
of information from MAOs.
NCQA and CMS will use information collected in the SNP Application
HPMS module to review and approve MOC narratives in order for an MAO to
offer a new SNP in the upcoming calendar year(s). This information is
used by CMS as part of the MA SNP application process. NCQA and CMS
will use information collected in the Renewal Submission section of the
HPMS MOC module to review and approve the MOC narrative for the SNP to
receive a new approval period and operate in the upcoming calendar
year(s). Form Number: CMS-10565 (OMB control number 0938-1296);
Frequency: Occasionally; Affected Public: Private Sector, Business or
other for-profits; Number of Respondents: 2,088; Total Annual
Responses: 2,088; Total Annual Hours: 8,638. (For policy questions
regarding this collection contact Daniel
[[Page 322]]
Lehman at 410-786-8929 or [email protected].)
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Request for
Termination of Medicare Premium Part A, Part B, or Part B
Immunosuppressive Drug Coverage (Part B-ID) and Supporting Statute and
Regulations; Use: Sections 1818(c)(5), 1818A(c)(2)(B) and 1838(b)(1) of
the Act and corresponding regulations at 42 CFR 406.28(a) and 407.27(c)
require that a Medicare enrollee wishing to voluntarily terminate Part
B or premium Part A coverage file a written request with CMS or SSA.
Pursuant to 1838(h) of the Act and the corresponding regulation at 42
CFR 407.62(a), individuals wishing to terminate their Part B-ID
coverage must notify SSA. The statute and regulations also specify when
coverage ends based upon the date the request for termination is filed.
The CMS-1763 is the form used by individuals who wish to terminate
their Medicare Part A, Part B or Part B-ID. This 2024 iteration is a
revision that does not propose any program changes. Per the Office of
Communication's plain language suggestion, the title has been updated
to ``Request for Termination of Medicare Premium Part A, Part B, or
Part B Immunosuppressive Drug Coverage (Part B-ID).'' The 2024
submission saw an increase in the burden due to utilization of the form
and improvement in the accuracy of the data exchanges between CMS and
SSA. Updated wage information for a Federal Government employee is also
responsible for part of the increase. Form Number: CMS-1763 (OMB
control number 0938-0025); Frequency: Biennially; Affected Public:
Private Sector--State, Local, or Tribal Governments; and Federal
Government; Number of Respondents: 197,518; Total Annual Responses:
197,518; Total Annual Hours: 33,578. (For policy questions regarding
this collection contact Tyrissa Woods at 410-786-0286 or
[email protected].)
William N. Parham, III,
Director, Division of Information Collections and Regulatory Impacts,
Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2024-31567 Filed 1-2-25; 8:45 am]
BILLING CODE 4120-01-P